(However,,2.8701690505786455)
(associated,2.8701690505786455)
(cancer,,2.8701690505786455)
(imaging,2.505525936990736)
(rapidly,2.3513752571634776)
((VEGFA,,2.3513752571634776)
((EF),,2.3513752571634776)
(techniques,2.3513752571634776)
(Observational,2.3513752571634776)
(ondata,2.3513752571634776)
(BC,2.3513752571634776)
(algorithm,2.3513752571634776)
(special,2.3513752571634776)
(harmless,2.3513752571634776)
(0.015).,2.3513752571634776)
(side,2.3513752571634776)
(50.,2.3513752571634776)
(concerns,2.3513752571634776)
(assessment,2.3513752571634776)
(requiring,2.3513752571634776)
(Similar,2.3513752571634776)
(include,2.3513752571634776)
(flow,2.3513752571634776)
(palliative,2.3513752571634776)
(concept,2.3513752571634776)
(Extra-Terminal,2.3513752571634776)
(suggesting,2.3513752571634776)
(generated,2.3513752571634776)
(prescriptions,2.3513752571634776)
(immunohistochemistry,2.3513752571634776)
(<,2.3513752571634776)
(NAC.,2.3513752571634776)
(improve,2.3513752571634776)
(3,2.3513752571634776)
(intrauterine,2.3513752571634776)
(LEVEL,2.3513752571634776)
(Breast,,2.3513752571634776)
(molecule,2.3513752571634776)
(population.,2.3513752571634776)
(inhibitory,2.3513752571634776)
(high-dose,2.3513752571634776)
(Bromodomain,2.3513752571634776)
(Because,2.3513752571634776)
(01.01.2010,2.3513752571634776)
(editing,2.3513752571634776)
(acute,2.3513752571634776)
(copyright.,2.3513752571634776)
(agents,,2.3513752571634776)
(allowed,2.3513752571634776)
(algorithm.,2.3513752571634776)
(IMAGING,2.3513752571634776)
(properly,2.3513752571634776)
(increment,2.3513752571634776)
(People,2.3513752571634776)
(drains,2.3513752571634776)
(micelles.,2.3513752571634776)
(36,2.3513752571634776)
(confirmation,2.3513752571634776)
(predictive,2.3513752571634776)
(greater,2.3513752571634776)
(met,2.3513752571634776)
(remained,2.3513752571634776)
(imagesneed,2.3513752571634776)
(Both,2.3513752571634776)
(syndromes.,2.3513752571634776)
(moist,2.3513752571634776)
(46.0,2.3513752571634776)
(Unfortunately,2.3513752571634776)
(substantial,2.3513752571634776)
(consultations.,2.3513752571634776)
(simplify,2.3513752571634776)
(Better,2.3513752571634776)
(considering,2.3513752571634776)
(motivation,2.3513752571634776)
(14,2.3513752571634776)
(refractory,2.3513752571634776)
(stratified,2.3513752571634776)
(HER2,,2.3513752571634776)
(evaluated,2.3513752571634776)
(non-ideal,,2.3513752571634776)
(b-cryptoxanthin,,2.3513752571634776)
(alternative,2.3513752571634776)
(routinely,2.3513752571634776)
(excision,2.3513752571634776)
(ion,2.3513752571634776)
(values,2.3513752571634776)
(personalistic,2.3513752571634776)
(purposively,2.3513752571634776)
((8,2.3513752571634776)
(literature.,2.3513752571634776)
(States,2.3513752571634776)
(checkpoint,2.3513752571634776)
(comprehensive,2.3513752571634776)
((NFPA),2.3513752571634776)
(Information,2.3513752571634776)
(system,number,2.3513752571634776)
(optoacoustic,2.3513752571634776)
(formation,2.3513752571634776)
(generally,2.3513752571634776)
(regional,2.3513752571634776)
(clustering,2.3513752571634776)
(intra-operative,2.3513752571634776)
(model,,2.3513752571634776)
(0.70,2.3513752571634776)
(result,,2.3513752571634776)
(images.,2.3513752571634776)
(radiologists,,2.3513752571634776)
(accumulation.,2.3513752571634776)
(dynamic,2.3513752571634776)
(Negative,2.3513752571634776)
(choice,2.3513752571634776)
(total,2.3513752571634776)
(avoid,2.3513752571634776)
(trials,2.3513752571634776)
(yielded,2.3513752571634776)
(utilized,2.3513752571634776)
(errors,2.3513752571634776)
(exploit,2.3513752571634776)
(recorded.,2.3513752571634776)
(microRNA,2.3513752571634776)
(towavelet,2.3513752571634776)
(93.45%,2.3513752571634776)
((NST),2.3513752571634776)
(contours.,2.3513752571634776)
(mammography,,2.3513752571634776)
(January,2.3513752571634776)
(status,,2.3513752571634776)
(clearly,2.3513752571634776)
(tomosynthesis,,2.3513752571634776)
(BMI,2.3513752571634776)
(Forty-two,2.3513752571634776)
(DEM,,2.3513752571634776)
(a-carotene,,2.3513752571634776)
(Guided,2.3513752571634776)
(focusing,2.3513752571634776)
(causation,2.3513752571634776)
(study.,2.3513752571634776)
(shared,2.3513752571634776)
(cancers.,2.3513752571634776)
(23,2.3513752571634776)
(larger,2.3513752571634776)
(J.,2.3513752571634776)
(summarize,2.3513752571634776)
(lower,2.3513752571634776)
(misdiagnosis,2.3513752571634776)
(transtuzumab.,2.3513752571634776)
(validated,2.3513752571634776)
(results.,2.3513752571634776)
(proportion,2.3513752571634776)
(negligible,2.3513752571634776)
(adjuvant,2.3513752571634776)
(interpretation,2.3513752571634776)
(Osteopontin-750,2.3513752571634776)
(atechnique,2.3513752571634776)
(intensity,2.3513752571634776)
((TNBC),2.3513752571634776)
(1062,2.3513752571634776)
(diagnoses,2.3513752571634776)
(study;,2.3513752571634776)
(investigate,2.3513752571634776)
(38.7%),2.3513752571634776)
(theory,2.3513752571634776)
(Diagnostic,2.3513752571634776)
(An,2.3513752571634776)
(update,2.3513752571634776)
(fraction.,2.3513752571634776)
(broader,2.3513752571634776)
(At,2.3513752571634776)
(MCL-1,2.3513752571634776)
(filters,2.3513752571634776)
(offer,2.3513752571634776)
(demographics,,2.3513752571634776)
(estradiol,2.3513752571634776)
(Multivariate,2.3513752571634776)
(cost,2.3513752571634776)
(precision,2.3513752571634776)
(decades,2.3513752571634776)
(oxide,2.3513752571634776)
(respectively.,2.3513752571634776)
(Given,2.3513752571634776)
(OS,,2.3513752571634776)
(detectionof,2.3513752571634776)
(clinic,2.3513752571634776)
(phantom,2.3513752571634776)
(Notably,,2.3513752571634776)
(hormone,2.3513752571634776)
(All,2.3513752571634776)
(segmentation,2.3513752571634776)
(1,444,2.3513752571634776)
(HER4),,2.3513752571634776)
(VEGFC,,2.3513752571634776)
(crucial,2.3513752571634776)
(difficult,2.3513752571634776)
(17,2.3513752571634776)
((DEM),,2.3513752571634776)
(cancercells,2.3513752571634776)
((NPV).,2.3513752571634776)
(network,2.3513752571634776)
(HER3,2.3513752571634776)
(kg/m2.,2.3513752571634776)
